Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC | 18,250 | reported | 18 Mar 2026 | tx 10+39,050−6,727 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Mar 2026 | GRANT_AWARD | CUMBERLAND PHARMACEUTICALS INC | 3,000 | 2.80 USD | deriv |
| 16 Mar 2025 | TAX_WITHHOLDING | CUMBERLAND PHARMACEUTICALS INC | 5,930 | 5.46 USD | |
| 17 Mar 2025 | GRANT_AWARD | CUMBERLAND PHARMACEUTICALS INC | 2,750 | 5.17 USD | deriv |
| 23 Mar 2024 | TAX_WITHHOLDING | CUMBERLAND PHARMACEUTICALS INC | 445 | 1.81 USD | |
| 25 Mar 2024 | GRANT_AWARD | CUMBERLAND PHARMACEUTICALS INC | 5,500 | 1.71 USD | deriv |
| 27 Nov 2023 | TAX_WITHHOLDING | CUMBERLAND PHARMACEUTICALS INC | 352 | 1.67 USD | |
| 24 Mar 2023 | GRANT_AWARD | CUMBERLAND PHARMACEUTICALS INC | 2,000 | 0.00 USD | deriv |
| 16 Mar 2022 | GRANT_AWARD | CUMBERLAND PHARMACEUTICALS INC | 20,000 | 2.59 USD | |
| 16 Mar 2022 | GRANT_AWARD | CUMBERLAND PHARMACEUTICALS INC | 2,000 | 0.00 USD | deriv |
| 23 Nov 2021 | PURCHASE | CUMBERLAND PHARMACEUTICALS INC | 3,800 | 2.35 USD |